As we reflect on #ObesityWeek2025 we are reminded of the close connection between obesity and Type 2 diabetes – complex metabolic conditions that affect multiple organs & call for a truly whole-body approach to assessment.

Read more on our website!

#Perspectum #DiabetesAwarenessMonth

Phenomix expands evidence for GLP-1 response predicting MyPhenome test New data show the MyPhenome test accurately predicts GLP-1 response and obesity risk across diverse populations.

Phenomix Sciences unveils new data at #ObesityWeek2025 showing its #MyPhenome test accurately predicts #GLP1 therapy response and obesity risk across diverse populations.

#News #PrecisionMedicine #ObesityResearch #HealthcareInnovation #Genomics #WeightLoss #Obesity

Phenomix expands evidence for GLP-1 response predicting MyPhenome test New data show the MyPhenome test accurately predicts GLP-1 response and obesity risk across diverse populations.

Phenomix Sciences unveils new data at #ObesityWeek2025 showing its #MyPhenome test accurately predicts #GLP1 therapy response and obesity risk across diverse populations.

#News #PrecisionMedicine #ObesityResearch #HealthcareInnovation #Genomics #WeightLoss #Obesity

Developing next generation weight loss medications? BMI only tells part of the story.

Find out more at www.perspectum.com/for-professionals/body-c... or book a meeting with our team at the upcoming Obesity Week, November 4-7, 2025

#Perspectum #obesityweek2025

Meet Our Experts at ObesityWeek® 2025!
Connect with Claudia Filozof, James Joyce and Peter Alfinito, Nov. 4–7 at Meeting Place 1.
Reach out to Alexis Freeland to set up a meeting and discover the latest in obesity research and care.
#ObesityWeek2025 #Obesity #DrugDevelopment #ClinicalTrials #CRO